Abstract

The Journal of Clinical Pharmacology and New DrugsVolume 13, Issue 2-3 p. 83-88 Pharmacologic Study of Cefazolin in Volunteers P. DE SCHEPPER M.D., Laboratories of Pharmacology and Pharmacotherapy, University of Louvain, Belgium; the Psychiatric Institute, Thienen, Belgium; and the Microbiological and Clinical Research Departments, R.I.T., Genval, Belgium.Search for more papers by this authorC. HARVENGT M.D., Laboratories of Pharmacology and Pharmacotherapy, University of Louvain, Belgium; the Psychiatric Institute, Thienen, Belgium; and the Microbiological and Clinical Research Departments, R.I.T., Genval, Belgium.Search for more papers by this authorC. VRANCKX M.D., Laboratories of Pharmacology and Pharmacotherapy, University of Louvain, Belgium; the Psychiatric Institute, Thienen, Belgium; and the Microbiological and Clinical Research Departments, R.I.T., Genval, Belgium.Search for more papers by this authorB. BOON Ph.D., Laboratories of Pharmacology and Pharmacotherapy, University of Louvain, Belgium; the Psychiatric Institute, Thienen, Belgium; and the Microbiological and Clinical Research Departments, R.I.T., Genval, Belgium.Search for more papers by this authorF. LAMY M.D., Laboratories of Pharmacology and Pharmacotherapy, University of Louvain, Belgium; the Psychiatric Institute, Thienen, Belgium; and the Microbiological and Clinical Research Departments, R.I.T., Genval, Belgium.Search for more papers by this author P. DE SCHEPPER M.D., Laboratories of Pharmacology and Pharmacotherapy, University of Louvain, Belgium; the Psychiatric Institute, Thienen, Belgium; and the Microbiological and Clinical Research Departments, R.I.T., Genval, Belgium.Search for more papers by this authorC. HARVENGT M.D., Laboratories of Pharmacology and Pharmacotherapy, University of Louvain, Belgium; the Psychiatric Institute, Thienen, Belgium; and the Microbiological and Clinical Research Departments, R.I.T., Genval, Belgium.Search for more papers by this authorC. VRANCKX M.D., Laboratories of Pharmacology and Pharmacotherapy, University of Louvain, Belgium; the Psychiatric Institute, Thienen, Belgium; and the Microbiological and Clinical Research Departments, R.I.T., Genval, Belgium.Search for more papers by this authorB. BOON Ph.D., Laboratories of Pharmacology and Pharmacotherapy, University of Louvain, Belgium; the Psychiatric Institute, Thienen, Belgium; and the Microbiological and Clinical Research Departments, R.I.T., Genval, Belgium.Search for more papers by this authorF. LAMY M.D., Laboratories of Pharmacology and Pharmacotherapy, University of Louvain, Belgium; the Psychiatric Institute, Thienen, Belgium; and the Microbiological and Clinical Research Departments, R.I.T., Genval, Belgium.Search for more papers by this author First published: February‐March 1973 https://doi.org/10.1002/j.1552-4604.1973.tb00257.xCitations: 5AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat Citing Literature Volume13, Issue2-3February‐March 1973Pages 83-88 RelatedInformation

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call